See What HealthDay Can Do For You
Contact Us

Home-Based Care Effective for Advanced HIV Infection

Study finds home-based as effective as facility-based care in Ugandan patients at lower cost

TUESDAY, Nov. 24 (HealthDay News) -- Home-based antiretroviral care is as effective as facility-based care for Ugandan patients with advanced HIV infection at much lower cost to the patient, according to a study published online Nov. 24 in The Lancet.

Shabbar Jaffar, Ph.D., from the London School of Hygiene and Tropical Medicine, and colleagues randomly assigned HIV-infected patients with late-stage disease in Jinja, Uganda, to either home-based care (859 patients) or facility-based care (594 patients).

After excluding patients who died, withdrew from the study, or were lost to follow-up, the researchers found that similar proportions of patients in the home and facility groups had virological failure (8.19 versus 8.67 per 100 person-years; rate ratio, 1.04) or died (5.40 versus 5.51 per 100 person-years; rate ratio, 0.95). The estimated annual costs were $793 for health services and $18 for patients for home care, compared with $838 for health services and $54 for patients for facility care.

"We have shown that home-based HIV care with antiretroviral therapy is an effective strategy, which relies less on clinical staff and hospital services than does facility-based care and provides large savings for patients," Jaffar and colleagues conclude.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.